Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 2, 2018

View Archived Issues

ANI Pharmaceuticals acquires NDAs, U.S. rights to four AstraZeneca products

CStone Pharmaceuticals announces IND filing in Australia

FDA clears Ignyta's IND for RXDX-106 study

Wanbang Biopharmaceuticals submits IND in China for SGLT2 inhibitor

FDA accepts Progenics' Azedra NDA for review

Siglec-7 targeting shows promise against multiple myeloma

Galapagos and Servier report ADAMTS inhibitors for osteoarthritis

CXCL12 shown to impact tipifarnib benefit in AML and MDS patients

Oncimmune signs framework agreement with Genostics for EarlyCDT platform in China

Vitae Pharmaceuticals patents Menin/MLL interaction inhibitors

GABA(A) receptor agonists reported in Sichuan Haisco Pharmaceutical patent

Phase III study of EG-1962 in aneurysmal subarachnoid hemorrhage recommended to continue

Universita del Piemonte Orientale prepares and tests CRAC modulators

GlaxoSmithKline patents describe ATF4 inhibitors

Atara cleared to begin phase III studies of tabelecleucel

Servier and Vernalis jointly patent USP7 inhibitors

ImmunoPrecise Antibodies invests in SERPINx to develop serine protease inhibitors

SELLAS Life Sciences Group completes merger with Galena Biopharma

Bio-Path updates pipeline progress

Global Foundation for Human Aging Research funds research at Dana-Farber into cellular aging

PHF2 expression impacts survival of ALL patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...